Sponsor(s):
Vanderbilt-Ingram Cancer Center
- Condition(s):
-
Breast Cancer
Basal Cell Carcinoma
Basal cell skin cancer
Cavities
Colon Cancer
Colorectal Cancer
Colorectal Carcinoma
Head Injury
Lethal Midline Granuloma
Lung Cancer
Male Breast Cancer
Metastatic cancer to the lung
Mouth Cancer
Nasopharyngeal Cancer
Non-Small Cell Lung Cancer
Oral Cancer
Prostate Cancer
Rectal Cancer
Salivary Gland Cancer
Salivary Gland Tumor
Skin Cancer
Small Cell Lung Cancer
Squamous Cell Carcinoma
Squamous Cell Skin Cancer
Cancer
Lung Disease
Adenocarcinoma
Blood Diseases and Disorders
Gastrointestinal Diseases and Disorders
Head and Neck Cancer
Lung Injury
Metastatic Cancer
Neoplasms
Oral Cavity Cancer
Rectal Disorders
Blood Disorder
Purpose:
RATIONALE: Measuring levels of growth factor in the blood of patients with cancer in the
laboratory may help doctors predict how patients will respond to treatment with radiation
therapy.
PURPOSE: This research study is looking at growth factor in patients with epithelial cancer
who are undergoing radiation therapy.
- Eligibility:
-
- Minimum Age:
- 18 Years
- Accepts Healthy Volunteers:
- No
DISEASE CHARACTERISTICS:
- Known diagnosis of an epithelial cancer, including any of the following:
- Head and neck
- Lung
- Breast
- Colorectal
- Prostate
- Radiotherapy must be a component of planned treatment therapy
PATIENT CHARACTERISTICS:
- No serious medical or psychiatric illnesses which would prevent informed consent
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Other Location(s):
Nashville, Tennessee United States,Nashville, Tennessee United States,Nashville, Tennessee United States
Terms:
This is an abstract courtesy of ClinicalTrials.gov,
a service of the US National Institute of Health Developed by the National Library
of Medicine. ClinicalTrials.gov provides regularly updates information about federally
and privately supported clinical research in human volunteers.
